Bin Wang

    • Shoreline Enters Partnership with Kite 

    • Shoreline Enters Collaboration with BeiGene 

    • Versartis $145 Million IPO 

    • Adamas Pharmaceuticals Initial Public Offering 

    • Atara – $63 Million IPO and Follow-On Offerings 

    • Nexvet Biopharma Closes Initial Public Offering 

    • KemPharm Completes its IPO 

    • Medivation Expanding Oncology Franchise with Acquisition of Talazoparib from BioMarin 

    • Eiger + Celladon Sign Merger Agreement 

    • Jazz Pharmaceuticals $125 Million Acquisition of ADX-N05 

    • Portola Pharmaceuticals $140 Million IPO 

    • EpimAb and Innovent Enter $120 Million Bispecific Antibody Partnership 

    • Fate Therapeutics Licensing and Platform Collaboration with Janssen Biotech 

    • Zai Lab Product Commercialization Collaboration with Regeneron 

    • Shoreline Biosciences Enters Collaboration With BeiGene to Develop Genetically Modified Cell Therapies